|
Active substance |
Elbasvir /grazoprevir |
|
Holder |
MSD |
|
Status |
Closed |
|
Indication |
Treatment of Chronic Kidney Disease stage 4/5 patients with hepatitis C genotype 1 or 4 infection |
|
Public documents |
|
|
Last update |
06/01/2017 |
Zepatier®
Last updated on 17/09/2024